Back to Search
Start Over
Cost-Effectiveness Analysis of Evolocumab Therapy in Patients at High Risk of Cardiovascular Events in the Context of the Brazilian Unified Health System.
- Source :
-
Arquivos brasileiros de cardiologia [Arq Bras Cardiol] 2021 Nov; Vol. 117 (5), pp. 988-996. - Publication Year :
- 2021
-
Abstract
- Background: Hypertrophic cardiomyopathy (HCM) and left ventricular hypertrophy (LVH) secondary to systemic hypertension (HTN) may be associated with left atrial (LA) functional abnormalities.<br />Objectives: We aimed to characterize LA mechanics in HCM and HTN and determine any correlation with the extent of left ventricular (LV) fibrosis measured by cardiac magnetic resonance (CMR) in HCM patients.<br />Methods: Two-dimensional speckle tracking-derived longitudinal LA function was acquired from apical views in 60 HCM patients, 60 HTN patients, and 34 age-matched controls. HCM patients also underwent CMR, with measurement of late gadolinium enhancement (LGE) extension. Association with LA strain parameters was analyzed. Statistical significance was set at p<0.05.<br />Results: Mean LV ejection fraction was not different between the groups. The E/e' ratio was impaired in the HCM group and preserved in the control group. LA mechanics was significantly reduced in HCM, compared to the HTN group. LA strain rate in reservoir (LASRr) and in contractile (LASRct) phases were the best discriminators of HCM, with an area under the curve (AUC) of 0.8, followed by LA strain in reservoir phase (LASr) (AUC 0.76). LASRr and LASR-ct had high specificity (89% and 91%, respectively) and LASr had sensitivity of 80%. A decrease in 2.79% of LA strain rate in conduit phase (LASRcd) predicted an increase of 1cm in LGE extension (r2=0.42, β 2.79, p=0.027).<br />Conclusions: LASRr and LASRct were the best discriminators for LVH secondary to HCM. LASRcd predicted the degree of LV fibrosis assessed by CMR. These findings suggest that LA mechanics is a potential predictor of disease severity in HCM.
- Subjects :
- Antibodies, Monoclonal, Humanized economics
Anticholesteremic Agents economics
Brazil
Contrast Media
Cost-Benefit Analysis
Gadolinium
Humans
State Medicine
Antibodies, Monoclonal, Humanized therapeutic use
Anticholesteremic Agents therapeutic use
Cardiomyopathy, Hypertrophic prevention & control
Hypertension drug therapy
Hypertrophy, Left Ventricular prevention & control
Subjects
Details
- Language :
- English; Portuguese
- ISSN :
- 1678-4170
- Volume :
- 117
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Arquivos brasileiros de cardiologia
- Publication Type :
- Academic Journal
- Accession number :
- 34817008
- Full Text :
- https://doi.org/10.36660/abc.20200690